ProPhase Labs Inc. announced amendments to its bylaws, which include updating the company's principal office address to RXR Plaza, Uniondale, New York. Additionally, stockholders approved a significant amendment to the company's Certificate of Incorporation, increasing the number of authorized shares of common stock from 50 million to 1 billion.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-013415), on September 15, 2025, and is solely responsible for the information contained therein.